The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4'-ethyl-N-{2-oxo-2-[(1-phenylpropyl)amino]ethyl}biphenyl-4-carboxamide ID: ALA3716774
PubChem CID: 58965390
Max Phase: Preclinical
Molecular Formula: C26H28N2O2
Molecular Weight: 400.52
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccc(-c2ccc(C(=O)NCC(=O)NC(CC)c3ccccc3)cc2)cc1
Standard InChI: InChI=1S/C26H28N2O2/c1-3-19-10-12-20(13-11-19)21-14-16-23(17-15-21)26(30)27-18-25(29)28-24(4-2)22-8-6-5-7-9-22/h5-17,24H,3-4,18H2,1-2H3,(H,27,30)(H,28,29)
Standard InChI Key: UXGKCQZWBHGMBU-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8999 -0.7576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9372 -1.3609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9336 -3.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -6.0109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1872 -7.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4854 -8.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1469 -8.1099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4855 -9.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7845 -10.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0836 -9.7649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0836 -8.2649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7846 -7.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3832 -10.5153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3857 -12.0154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6859 -12.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9837 -12.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9814 -10.5114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6812 -9.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2862 -12.7571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-15.3236 -12.1540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
7 10 1 0
10 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 16 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
20 23 1 0
26 29 1 0
29 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 400.52Molecular Weight (Monoisotopic): 400.2151AlogP: 4.91#Rotatable Bonds: 8Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.78CX Basic pKa: ┄CX LogP: 5.21CX LogD: 5.21Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: -1.06
References 1. (2007) Tao Kinase Modulators And Method Of Use,